Initial treatment of the majority of patients with differentiated thyroid cancer (DTC) includes
total thyroidectomy. Postoperative ablation therapy with radioactive iodine (I-131) is …

Context: Recent trial results have revived interest in low-activity initial 131I therapy (RIT) of
differentiated thyroid cancer (DTC). Objective: This study sought to compare different initial …

Simple Summary This year marks the 80th commemoration of the first time that radio-iodide
treatment (RAI) was used. RAI is one of the most effective targeted internal radiation …

Controversy exists over optimal management of low-risk differentiated thyroid cancer. This
controversy occurs in all aspects of management, including surgery, use of radioactive …

Simple Summary Radioactive iodine treatment is the oldest targeted therapy for
differentiated thyroid cancer. It can be used for normal thyroid remnant ablation (in order to …

(1) In radiation therapy, cancer is treated to preserve life and to improve the quality of life of
the patient. While radiation therapy focuses on treating the malignancy, absorbed doses …

Thyroid cancer is increasing all over the world. The exact cause of this increase is still
debated and there are conflicting reports. Sophisticated molecular studies suggest that …

Background Postoperative radioactive iodine (RAI) administration is widely utilized in
patients with differentiated thyroid cancer. While beneficial in select patients, it is critical to …

Context: The use of preablation diagnostic radioiodine scans for risk stratification and
radioiodine therapy planning for differentiated thyroid cancer (DTC) remains controversial …

The decay product of the medical isotope molybdenum-99 (Mo-99), technetium-99m (Tc-
99m), and associated medical isotopes iodine-131 (I-131) and xenon-133 (Xe-133) are …